ReviewJournal of robotic surgery2026
Robot-assisted kidney transplantation in obese recipients: wound-risk reduction, graft safety, and access implications.
Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Obese kidney transplant recipients are at increased risk of surgical site infection, impaired wound healing, lymphocele, hematoma, and incisional hernia, and these wound-related risks have led some transplant programs to apply restrictive body mass index (BMI) thresholds. Robot-assisted kidney transplantation (RAKT) provides a minimally invasive approach by combining small-incision graft insertion with three-dimensional visualization, wristed instrumentation, and intracorporeal vascular and ureteral reconstruction. In obese recipients, this approach may reduce abdominal wall trauma while preserving precision during deep pelvic dissection and anastomosis. This narrative review summarizes the technical rationale, wound-related outcomes, perioperative results, graft safety, candidate selection, learning-curve considerations, and potential access implications of RAKT in obese recipients. Available evidence, mainly from retrospective cohorts, experienced-center series, and meta-analyses, suggests that RAKT may be associated with lower surgical site infection rates and acceptable short- to mid-term graft function in carefully selected patients. However, current evidence does not establish routine superiority over open kidney transplantation (OKT) or demonstrate improved waiting-list entry, listing, or transplantation rates. Important remaining barriers include rewarming-time control, regional hypothermia, vascular calcification, pneumoperitoneum management, cost-effectiveness, and limited long-term data. Future multicenter studies should integrate imaging-based risk stratification, standardized hypothermia protocols, structured training, and multidisciplinary weight-management pathways to define the role of RAKT in reducing wound-related morbidity and informing access-related decision-making in selected obese candidates.
Indexed as
Identifiers
42487013What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.